Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-28 Sale | 2023-08-29 5:04 pm | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $6.2757 | $98,058 | 148,975 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-18 Option Award | 2024-09-20 5:47 pm | N/A 2034-09-17 | Structure Therapeutics Inc. | GPCR | Hall Ashley Chief Development Officer | 150,180 | $0 | 150,180 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-29 5:04 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $0 | 148,975 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-29 5:04 pm | N/A N/A | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 15,625 | $1.8 | 148,975 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 6:11 pm | N/A 2032-12-08 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 125,000 | $0 | 160,600 (Direct) | View |
| 2021-11-12 Option Award | 2021-11-15 7:49 pm | N/A 2031-11-11 | Reneo Pharmaceuticals Inc. | RPHM | Hall Ashley Chief Development Officer | 210,000 | $0 | 210,000 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 5:01 pm | N/A 2031-01-28 | Esperion Therapeutics Inc. | ESPR | Hall Ashley Chief Development Officer | 38,000 | $0 | 53,500 (Direct) | View |
Ownership | 2020-02-28 4:39 pm | N/A N/A | Esperion Therapeutics Inc. | ESPR | Hall Ashley Chief Development Officer | 0 | $0 | 381,250 (Direct) | View |